Cui et al. showed that the downregulation of PPP2R2A by CRISPR/Cas9-mediated deletion inhibits the growth of non-small cell lung cancer cells (Cui et al., 2020), which was similar to the results of this study. Here, PPP2R2A is linked to non-small cell lung carcinoma.